Adverse Event Clinical Research R4 Backport
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example AdverseEvent: adverse-event-compass-ex1a

Generated Narrative: AdverseEvent

Resource AdverseEvent "adverse-event-compass-ex1a"

Profile: Adverse Event Clinical Research

Resulting Effect: : Reference to Observation of Alanine aminotransferase (ALT) increased at 200

Supporting information relevant to the event

url

item

value: : Supporting info would have context such as an Reference to Observation of Alanine aminotransferase (ALT) increased at 200

Adverse Event Grade: Grade 3 Severe Adverse Event (NCI Thesaurus#C41340)

Participant

url

function

value: authenticator (ParticipationType#AUTHEN)

url

actor

value: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"

Suspect Entity

url

instance

value: MedicationAdministration/medication-administration-kadcyla

url

causality

Suspect Entity

url

instance

value: MedicationAdministration/medication-administration-tucatinib

url

causality

Expected In Research Study: true

Note: treatment held today per protocol guidelines and the patient was scheduled to return in one week for repeat lab work

modifierExtension[http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status]

actuality: actual

event: Alanine aminotransferase (ALT) increased to 200 (Medical Dictionary for Regulatory Activities#10001551 "Alanine aminotransferase increased")

subject: Patient/patient-example-kaitlyn-b " BOUNCE"

date: 2020-05-13

seriousness: Non-serious (AdverseEventSeriousness#non-serious)

outcome: Not recovering/not resolved (NCI Thesaurus#C49494)

recorder: Practitioner/practitioner-oncology-nurse-jane " NURSE"

study: ResearchStudy/clinical-trial-example-compass